<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"dysphagia":1,
"esophagus":1,
"schwannoma":1,
"thyroid":17,
"ultrasonography":3,
"lobectomy":2,
"minimally invasive":1,
"nodulectomy":1,
"single thyroid nodule":1,
"anti-thyroglobulin antibody":1,
"mortality":2,
"recurrence":3,
"total thyroidectomy":2,
"Carcinoma espinocelular":1,
"Faringectomia":1,
"Hipofaringe":1,
"Hypopharynx":2,
"Laringe":1,
"Laringectomia":1,
"Laryngectomy":2,
"Larynx":3,
"Pharyngectomy":1,
"Squamous cell carcinoma":1,
"Thyroidectomy":6,
"Tireoidectomia":1,
"Radiotherapy":2,
"glottic cancer":1,
"BRAFV600E":1,
"NADPH oxidase":1,
"NIS":1,
"NOX4":1,
"ROS":1,
"papillary thyroid cancer":7,
"Protein kinase A":1,
"Thyroid cancer":23,
"cAMP analogs":1,
"BRAF V600E mutation":1,
"Liquid-based cytology":2,
"MCTs":1,
"PTC":3,
"Plump cells":1,
"Thyroid lesions":2,
"ACTH = adrenocorticotropic hormone":1,
"B-cell":1,
"DLBCL = diffuse large B-cell lymphoma":1,
"GHRH = growth hormone–releasing hormone":1,
"IGF-1 = insulin-like growth factor-1":1,
"NHL = non-Hodgkin lymphoma":1,
"PCNSL = primary central nervous system lymphoma":1,
"R-CHOP = rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate, and prednisone":1,
"SIADH = syndrome of inappropriate antidiuretic hormone":1,
"TSH = thyroid-stimulating hormone":1,
"lymphoma":1,
"pituitary surgery":1,
"somatotroph hyperplasia":1,
"diffuse optical tomography, light propagation in tissues, radiative transfer equation, thyroid cancers in human neck":1,
"CME":1,
"Complete mesocolic excision":1,
"Gastrocolic trunk":1,
"Laparoscopy":1,
"Transverse colon cancer":1,
"differentiated thyroid cancer":7,
"extrathyroidal extension":1,
"medullary thyroid cancer":3,
"AFM":1,
"Cancer cells":1,
"Polyacrylamide gels":1,
"Stress relaxation":1,
"Viscoelastic properties":1,
"dosimetry":1,
"endocrine":1,
"oncology":2,
"radioactive iodine":2,
"radionuclide therapy":2,
"Laryngeal cancer":1,
"differentially expressed genes":1,
"feature genes":1,
"support vector machine":1,
"survival analysis":2,
"axillary lymph node metastasis":1,
"breast cancer":5,
"nomogram":1,
"prediction model":1,
"Familial non-medullary thyroid cancer":1,
"G534E":1,
"HABP2":1,
"Italian population":1,
"Cytopathology":1,
"Geriatric":1,
"Histopathology":1,
"DTC":1,
"DxWBS":1,
"Follow-up":1,
"sTg":1,
"BRAF mutation":2,
"fine-needle aspiration biopsy":1,
"morphometry":1,
"papillary thyroid carcinoma":11,
"undetermined cytology":1,
"Follicular neoplasm":1,
"malignancy":2,
"thyroglobulin":1,
"PD-1":1,
"Polymorphism":2,
"complications":2,
"radiation":2,
"readmission":1,
"smoking":1,
"National Cancer Data Base":1,
"anaplastic thyroid carcinoma":5,
"head and neck":1,
"propensity-score matching":1,
"radiation therapy":1,
"TSH suppression":1,
"subclinical thyrotoxicosis":1,
"Hürthle cell carcinoma":1,
"RAS":1,
"TERT":1,
"distant metastasis":1,
"follicular variant":2,
"pathologic size":1,
"thyroid nodules":2,
"ultrasound size":1,
"BRAF":1,
"anaplastic thyroid cancer":2,
"chemotherapy":2,
"p53":1,
"thyroid surgery":2,
"undifferentiated":1,
"Low risk thyroid cancer":1,
"papillary microcarcinoma":2,
"staging":1,
"Lymphatic metastasis":1,
"surgery":5,
"thyroid gland":5,
"thyroid neoplasms":3,
"ABC transporter":1,
"Breast cancer resistant protein":1,
"Cabozantinib":2,
"Multidrug resistance":1,
"lesion-based dosimetry":1,
"radioiodine":2,
"response to radioiodine":1,
"thyroid cancer metastases":1,
"Cancer":6,
"kinase inhibitors":1,
"re-differentiation":1,
"Afirma gene expression classifier":1,
"architectural atypia":1,
"atypia of undetermined significance (AUS)":1,
"cytologic atypia":1,
"cytology":5,
"follicular lesion of undetermined significance (FLUS)":1,
"indeterminate cytology":1,
"thyroid nodule":6,
"TERT promoter mutation":1,
"prognosis":4,
"computed tomography":2,
"dog":1,
"thyroid carcinoma":5,
"thyroid incidentaloma":2,
"thyroid mass":1,
"Anaplastic and papillary thyroid carcinoma":1,
"Carcinomes anaplasiques et papillaires de la thyroïde":1,
"Immunohistochemistry":3,
"Immunohistochimie":1,
"Marqueurs moléculaires":1,
"Molecular marker":1,
"convolutional neural network":1,
"detection":1,
"feature extraction":1,
"segmentation":1,
"ultrasound image":1,
"Beckman coulter":1,
"DxI platform":1,
"Immunoassay methods":1,
"Quality control":1,
"Quality specification":1,
"TSH":1,
"Bethesda":1,
"fine-needle aspiration (FNA)":1,
"noninvasive":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"diagnosis":4,
"molecular diagnostics":1,
"pathology":1,
"recent advances":1,
"aspiration cytology":1,
"cribriform adenocarcinoma of the minor salivary gland":1,
"head and neck cancer":1,
"Antiestrogen":1,
"GANT61":1,
"breast cancer stem cells":1,
"estrogen":1,
"hedgehog signaling pathway":1,
"Elasticity imaging, tissue":1,
"Imaging procedures":1,
"Liver":1,
"Tissue characterization":1,
"Tumor detection":1,
"Bladder":1,
"Breast":2,
"Case report":2,
"Lynch syndrome":1,
"Multiple primary tumor":1,
"Uterus":1,
"CD56":1,
"CK19":1,
"Mimicking thyroid lesions":1,
"Associated malignant tumor":1,
"Choroid plexus papilloma":1,
"Intraoperative consultation":1,
"Mature teratoma":1,
"Ovary":1,
"Postmenopausal women":1,
"atypical":1,
"interobserver":1,
"the Bethesda system":1,
"variability":1,
"CAD":1,
"Classification":1,
"Fractal features":1,
"Marginal fisher analysis":1,
"fine needle aspiration":1,
"solid variant":1,
"Aerobic glycolysis":1,
"CagA":1,
"cancer development":1,
"gastric cancer":2,
"pyruvate kinase":1,
"gene expression":1,
"molecular genetics":1,
"EWSR1 rearrangement":1,
"EWSR1-FLI1":1,
"Ewing sarcoma":1,
"Small cell carcinoma":1,
"NSCLC":1,
"Non-squamous":1,
"Platinum-pemetrexed doublet":1,
"TTF1":1,
"Graves disease":1,
"Hashimoto thyroiditis":1,
"autoimmune thyroiditis":1,
"hyperthyroidism":2,
"hypothyroidism":2,
"vitiligo":1,
"exfoliative cytology":1,
"fine-needle aspiration cytology":1,
"nongynecologic cytology":1,
"quality assurance":1,
"Ductal carcinoma in situ":1,
"Multicenter study":1,
"Ultrasound":5,
"primary thyroid lymphoma":1,
"primary thyroid sarcoma":1,
"bilateral breast approach":1,
"intraoperative neuromonitoring":1,
"percutaneous stimulation":1,
"recurrent laryngeal nerve":3,
"total endoscopic thyroidectomy":1,
"Bone":2,
"Extraskeletal myxoid chondrosarcoma":1,
"Molecular analysis":1,
"extension":1,
"extrathyroidal":1,
"minimal extrathyroidal extension":1,
"survival":4,
"central compartment lymph nodes":1,
"lateral compartment lymph nodes":1,
"lymphatic pathways":1,
"neck dissection":5,
"prophylactic neck dissection":1,
"skip metastases":1,
"Focal liver lesions":1,
"Fusion imaging":1,
"Hepatocellular carcinoma (HCC)":1,
"Radiofrequency ablation (RFA)":1,
"Transarterial chemoembolization (TACE)":1,
"National Lung Screening Trial":1,
"body size":1,
"effective dose":1,
"low-dose CT":1,
"organ dose":1,
"multikinase inhibitor":1,
"noninterventional":1,
"observational":1,
"radioactive iodine refractory":1,
"sorafenib":1,
"MEN2":1,
"anxiety":1,
"coping":1,
"depression":1,
"medullary thyroid carcinoma":1,
"quality of life":2,
"Immunocytochemistry":1,
"Lung adenocarcinoma":1,
"Pleural effusions":1,
"Acquired Subglottic Stenosis":1,
"Airway Obstruction":1,
"Tracheal Stenosis":1,
"Phase II":1,
"Sunitinib":1,
"Advanced thyroid cancer":2,
"adverse events":1,
"molecular targets":1,
"targeted therapy":1,
"tyrosine kinase inhibitors":1,
"Sistrunk procedure":1,
"papillary carcinoma":4,
"thyroglossal duct cyst carcinoma":1,
"active surveillance":1,
"management":1,
"overdiagnosis":1,
"overtreatment":1,
"terminology":1,
"+49A&gt":1,
"G":2,
"-318C&gt":1,
"T":1,
"CT60A&gt":1,
"CTLA-4 gene":1,
"differentiated thyroid carcinoma":1,
"efficacy":1,
"radioiodine-131":1,
"focused ultrasound":1,
"nodule shrinkage":1,
"thermal ablation":1,
"core-needle biopsy":1,
"fine-needle aspiration":2,
"ultrasound imaging":1,
"BRAF V600E":1,
"HMGB1":1,
"ALK":1,
"mutations":2,
"new-generation sequencing":1,
"translocation":1,
"Anti-TNF agent":1,
"Axial spondyloarthritis":1,
"Thyroid malignancy":1,
"Multimodality":1,
"Surgical management":2,
"management guidelines":1,
"bilateral surgery":1,
"extensive thyroid cancer":1,
"intraoperative nerve monitoring":1,
"staged surgery":1,
"Didelphis virginiana":1,
"Virginia opossums":1,
"marsupial":1,
"neoplasia":2,
"Escin":1,
"pharmacokinetics":1,
"side effects":1,
"EGFR/ERK2":1,
"PKM2":1,
"Warburg effect":1,
"iNOS":1,
"nitric oxide":1,
"Cystadenoma":1,
"Feline":1,
"FNA":1,
"Hashimoto's thyroiditis":1,
"subcentimeter nodules":1,
"Reporting":1,
"Surgical wait time":1,
"Endothelial dysfunction":1,
"Lenvatinib":1,
"Vascular endothelial growth factor":1,
"Comorbidities":1,
"Elderly":1,
"Molecular imaging":1,
"Prostate cancer":2,
"Radionuclide imaging":1,
"Radium-223":1,
"ER+":1,
"G1/S":1,
"MiR-206":1,
"WBP2":1,
"Cardiovascular diseases":1,
"Metformin":1,
"Neoplasms":1,
"Non-diabetes":1,
"All-trans retinoic acid":1,
"Apoptosis":1,
"Breast cancer cells":1,
"Docking protein 1":1,
"Peroxisome proliferator activated receptor gamma":1,
"Proliferation":2,
"IMRT":1,
"fixed collimator jaws technique":1,
"regional lymph node":1,
"Helicobacter pylori":1,
"TLR5":1,
"genetic":1,
"variation":1,
"Follicular carcinoma":2,
"PET":1,
"Cancer registries":1,
"EUROCARE":1,
"Europe":1,
"Papillary":1,
"Relative survival":2,
"Docetaxel":1,
"STARD10":1,
"miR-638":1,
"Apaptosis":1,
"HSP90 inhibitor":1,
"NVP-AUY922":1,
"Survivin":1,
"CXCR1":1,
"CXCR2":1,
"Reparixin":1,
"DNA methylation":2,
"EZH2":1,
"METTL7A":1,
"gene body":1,
"Advanced cancer patient":1,
"Cyclin-dependent kinase inhibitors":1,
"Gemcitabine":1,
"Milciclib":1,
"FOXD3":1,
"MAPK/ERK signal pathway":1,
"human anaplastic thyroid cancer":1,
"metastasis":1,
"Clinical and dosimetric predictors":1,
"Intensity-modulated radiotherapy":1,
"Nasopharyngeal carcinoma":1,
"Hyoid bone":1,
"adenocarcinoma metastases":1,
"computerized tomography bone scintigraphy":1,
"thyroid cartilage":2,
"Benign thyroid nodule":1,
"Ethanol":1,
"Image-guided ablation":1,
"Radiofrequency":1,
"Epidemiology":2,
"Non–small cell lung cancer":1,
"Surveillance":1,
"and End Results":1,
"incidence":1,
"race":1,
"socioeconomic status":1,
"celastrol":1,
"paclitaxel":1,
"synergism":1,
"Next-generation sequencing":1,
"endocrine cancer":1,
"4D CT":1,
"Primary hyperparathyroidism":3,
"parathyroidectomy":1,
"Lymph Nodes":1,
"Parathyroid Neoplasms":1,
"BRAFV600E mutation":1,
"FGF signaling pathway":1,
"Integrative analysis":1,
"Retinoic acid pathway":1,
"Children and adolescents":1,
"Clinical characteristics":1,
"Surgical treatment":1,
"hypergravity":1,
"microgravity":1,
"space environment":1,
"Incision":1,
"Lateral neck dissection":1,
"Lymph node dissection":1,
"Selective neck dissection":1,
"The Cancer Genome Atlas":1,
"cell cycle":1,
"Algorithm":1,
"Methods":1,
"Validation":1,
"Advanced cell renal carcinoma":1,
"Cancer bronchique non à petites cellules":1,
"Cancer de la prostate":1,
"Cancer du rein":1,
"Cancer médullaire de la thyroïde":1,
"Lung cancer":3,
"MET receptor":1,
"Récepteur MET":1,
"99mTc-MDP bone scintillation imaging":1,
"99mTc-MIBI thyroid imaging":1,
"Metastatic pulmonary calcification":1,
"ARID2":1,
"Adenocarcinoma":1,
"Bladder cancer":1,
"Clear cells":1,
"TTF-1":2,
"DNA repair":1,
"Genetic susceptibility":1,
"MGMT":1,
"Radiation-induced cancer":1,
"Breast cancer screening":1,
"Childhood cancer":1,
"Childhood cancer survivor":1,
"Second cancer":1,
"Secondary cancer":1,
"Survivor":1,
"Thyroid cancer screening":1,
"Young age papillary thyroid cancer":1,
"Bethesda classification":1,
"Guidelines":1,
"Completion thyroidectomy":1,
"Hemithyroidectomy":1,
"Papillary thyroid microcarcinoma":1,
"Risk stratification":1,
"Morbidity":1,
"Prophylactic central neck dissection":1,
"Treatment":2,
"Medical malpractice":1,
"Recurrent laryngeal nerve injury":1,
"Atypia of undetermined significance":1,
"Fine needle cytology":1,
"Fine needle aspiration cytology":1,
"Molecular diagnosis":1,
"TI-RADS":1,
"Carcinoma":1,
"Lymph node":1,
"Medullary":1,
"Metastases":2,
"99m Tc-MIBI scintigraphy":1,
"MIBI uptake":1,
"Radioguided surgery":1,
"Thyroid follicular neoplasm":1,
"RFA":1,
"Radiofrequency ablation":1,
"Radiofrequency thermal ablation":1,
"Adult intensive care":1,
"Cancer intervention":1,
"Geriatric medicine":1,
"Valvar diseases":1,
"arteriovenous malformation":1,
"presentation":1,
"renal cell cancer":1,
"thyroid metastasis":1,
"unusual":1,
"cyclooxygenase 2":1,
"non-metastatic expressed/non-metastatic 23 nucleoside diphosphate kinase 1":1,
"thyroid papillary carcinoma":1,
"thyroid papillary microcarcinoma":1,
"B-Raf proto-oncogene":1,
"age":1,
"aggressiveness":1,
"size":1,
"tall cell variant":1,
"claudin 1":1,
"claudin 4":1,
"claudin 7":1,
"thyroid neoplasia":1,
"tight junctions":1,
"Pigment epithelium-derived factor":1,
"V-raf murine sarcoma viral oncogene homolog B1 V600E":1,
"CyberKnife M6™":1,
"Peripheral dose":1,
"Stereotactic radiosurgery":1,
"Cancer specific survival":1,
"Disease free interval":1,
"Hurthle cell carcinoma":1,
"adult thyroid":1,
"cardiovascular":1,
"clinical":1,
"general":1,
"Coblation":1,
"Surgical procedures, minimally invasive":1,
"Tongue neoplasms":1,
"Hypopharyngeal cancer":1,
"Laryngeal neoplasm":1,
"Magnetic resonance imaging":1,
"High throughput sequencing":1,
"Log-rank test":1,
"Rule induction":1,
"Separate-and-conquer":1,
"HOX transcript antisense RNA":1,
"biomarker":1,
"long non-coding RNAs":1,
"Calcium and bone":1,
"Metabolic disorders":1,
"Laparoscopic":1,
"Pancreas metastasis":1,
"Pancreatectomy":1,
"Renal cell carcinoma":2,
"Regional recurrence":1,
"I-131":1,
"benign stenosis":1,
"drug-eluting stents":1,
"stents":1,
"Demography":1,
"Head and neck neoplasms":2,
"Iran":1,
"Actinomycosis":1,
"Fistula":1,
"undifferentiated thyroid cancer":1,
"medullary thyroid":1,
"CK5/6":1,
"Histological classification":1,
"NapsinA":1,
"P63":1,
"Chromogranin":1,
"Pan cytokeratin":1,
"Synaptophysin":1,
"Genetic therapy":1,
"Palliative care":1,
"Patient comfort":1,
"Ectopic thyroid":1,
"MRI":1,
"paraganglioma":1,
"Follicular Adenoma":1,
"Galactin-3":1,
"Neuroendocrine tumors":1,
"small cell neuroendocrine carcinoma":1,
"small round blue cell tumors":1,
"TSHR mRNA":1,
"noninvasive detection":1,
"peripheral blood":1,
"Helicobacter pylori infection":1,
"disadvantaged population":1,
"social determinants of health":1,
"socioeconomic development":1,
"urban-rural disparity in cancer":1,
"urbanization":1,
"FDG-avid":1,
"Oncocytoma":1,
"PET/CT":1,
"Renal mass":1,
"capillarity":1,
"fine-needle biopsy":1,
"Cowden syndrome":1,
"PTEN":1,
"ganglioneuroma":1,
"hamartoma":1,
"osteosarcoma":1,
"CaSR":1,
"Parathyroid adenoma":1,
"p27 Kip1":1,
"malignant solitary fibrous tumor":1,
"thyroid tumor":1,
"inflammatory myofibroblastic tumor":1,
"fatigue":1,
"patient reported outcome measures":1,
"survivals":1,
"DNA analysis":1,
"Follicular neoplasms":1,
"Thyroid FNA":1,
"miRNAs":1,
"Extramedullary plasmacytoma":1,
"HIV infection":1,
"Ureter":1,
"CD14":1,
"Innate immunity":1,
"Pattern recognition receptor":1,
"Toll like receptor":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2017年5月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
